over initiation/dose escalation of glucocorticoids for patients with a serious infection within the previous 12 months who have moderate-to-high disease activity This conditional recommendation is made based on observational studies suggesting a strong association between dose and duration of glucocorticoids with the risk of serious infection Nontuberculous mycobacterial (NTM) lung disease Given the variability of NTM lung disease severity and response to treatment, patients should be closely